These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 9725211

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I.
    Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
    Kayagaki N, Yamaguchi N, Nakayama M, Takeda K, Akiba H, Tsutsui H, Okamura H, Nakanishi K, Okumura K, Yagita H.
    J Immunol; 1999 Aug 15; 163(4):1906-13. PubMed ID: 10438925
    [Abstract] [Full Text] [Related]

  • 6. TNF-related apoptosis-inducing ligand death pathway-mediated human beta-cell destruction.
    Ou D, Metzger DL, Wang X, Huang J, Pozzilli P, Tingle AJ.
    Diabetologia; 2002 Dec 15; 45(12):1678-88. PubMed ID: 12488957
    [Abstract] [Full Text] [Related]

  • 7. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells.
    Griffith TS, Chin WA, Jackson GC, Lynch DH, Kubin MZ.
    J Immunol; 1998 Sep 15; 161(6):2833-40. PubMed ID: 9743343
    [Abstract] [Full Text] [Related]

  • 8. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD, Wu JJ, Gillespie S, Borrow J, Hersey P.
    Clin Cancer Res; 2006 Feb 15; 12(4):1355-64. PubMed ID: 16489094
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The human melanoma cell line MelJuSo secretes bioactive FasL and APO2L/TRAIL on the surface of microvesicles. Possible contribution to tumor counterattack.
    Martínez-Lorenzo MJ, Anel A, Alava MA, Piñeiro A, Naval J, Lasierra P, Larrad L.
    Exp Cell Res; 2004 May 01; 295(2):315-29. PubMed ID: 15093732
    [Abstract] [Full Text] [Related]

  • 13. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
    Lawrence CP, Chow SC.
    FEBS Lett; 2005 Nov 21; 579(28):6465-72. PubMed ID: 16289096
    [Abstract] [Full Text] [Related]

  • 14. Cisplatin down-regulation of cellular Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory proteins to restore tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human melanoma cells.
    Song JH, Song DK, Herlyn M, Petruk KC, Hao C.
    Clin Cancer Res; 2003 Sep 15; 9(11):4255-66. PubMed ID: 14519653
    [Abstract] [Full Text] [Related]

  • 15. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria.
    Zhang XD, Zhang XY, Gray CP, Nguyen T, Hersey P.
    Cancer Res; 2001 Oct 01; 61(19):7339-48. PubMed ID: 11585775
    [Abstract] [Full Text] [Related]

  • 16. In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma.
    Tian JQ, Wang ZP, Rodriguez R, Fu JS, Lu JZ, Ma BL.
    Urology; 2006 May 01; 67(5):1093-8. PubMed ID: 16635513
    [Abstract] [Full Text] [Related]

  • 17. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis.
    Seol DW, Li J, Seol MH, Park SY, Talanian RV, Billiar TR.
    Cancer Res; 2001 Feb 01; 61(3):1138-43. PubMed ID: 11221844
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.